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Abstract
Background: Calcium phosphate manufactured samples, prepared with hydroxyapatite, are used
as either spacers or fillers in orthopedic surgery, but these implants have never been used under
conditions of mechanical stress. Similar conditions also apply with cements. Many authors have
postulated that cements are a useful substitute material when implanted in vivo. The aim of this
research is to develop a low cristalline material similar to bone in porosity and cristallinity.
Methods: Commercial hydroxyapatite (HAp) and monetite (M) powders are mixed with water
and compacted to produce cylindrical samples. The material is processed at a temperature of 37–
120 degrees C in saturated steam to obtain samples that are osteoconductive. The samples are
studied by X-ray powder diffraction (XRD), Vickers hardness test (HV), scanning electron
microscopy (SEM), and porosity evaluation.
Results: The X-ray diffractions of powders from the samples show patterns typical of HAp and M
powders. After thermal treatment, no new crystal phase is formed and no increase of the relative
intensity of the peaks is obtained. Vicker hardness data do not show any relationship with
treatment temperature. The total porosity decreases by 50–60% according to the specific thermal
treatment. Scanning electron microscopy of the surfaces of the samples with either HAp 80%-M
20% (c) or Hap 50%-M 50% (f), show cohesion of the powder grains.
Conclusions: The dissolution-reprecipitation process is more intesive in manufactured samples
(c) and (f), according to Vickers hardness data. The process occurs in a steam saturated
environment between 37 degrees and 120 degrees C. (c) (f) manufactured samples show pore
dimension distributions useful to cellular repopulation in living tissues.
Background
From about 1990, calcium phosphate manufactured sam-
ples, typically produced with hydroxyapatite, are used as
spacers or fillers in orthopedic reconstruction and as fill-
ers in maxillofacial applications, [1-10], however, these
implants have never been used under mechanical stress.
Also, cements have been increasingly employed in cranio-
facial trauma surgery and dentistry [11-14], and after time
these implants are reabsorbed and replaced by newly
formed mineralized matrix.
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At present many researchers prefer to produce macropo-
rous ceramics, which are biologically compatible and
show osteoinductive properties [15,16]. That is when they
are implanted in vivo in ectopic areas, new mineral bone
matrix is detectable after only six months.
If porous ceramics are prepared with organic matrices,
such as collagen type I [17,18], and bone marrow cells
[19,20], they show osteogenic activity even if implanted
in bone tissue and ectopic areas of experimental animals
and in vitro cultures.
The cements are obtained from powders mixed in water
and hardened for a short time at 37°C [21,22]. The pre-
ferred phosphates are monetite (CaHPO4) and brushite
(CaHPO4.2H2O) [22-25]. These products give hydroxyap-
atite precipitates, so the cements harden and often are sug-
gested as repair materials in those regions that are not
under mechanical stress.
Many authors postulate that such compounds are useful
as substitute materials when implanted in vivo. The
replacement of these materials by ex novo formed bone
occurs by a combination of osteoconduction and implant
resorption [12-14].
The aim of the present research is to obtain low crystalline
materials similar to bone in porosity and cristallinity. Our
manufactured samples are characterized by X-ray powder
diffraction (XRD), scanning electron microscopy (SEM),
Vickers hardness test (HV) determination, porosity evalu-
ation and calcium solubility of the powders used to pro-
duce the fillers.
The data obtained are extremely useful in evaluating the
chemico-physical properties of manufactured samples
and should be extremely useful in interpreting the mor-
phological and X-ray diffraction data. The relationships
among these data could help facilitate production of the
fillers that we have studied.
Methods
Hydroxyapatite (Ca10 (PO4)6 (OH)2), (HAp) and mon-
etite (CaHPO4), (M) from Aldrich (Sheboygan, WI, USA)
are used to prepare manufactured samples. Both powders
are mechanically mixed for one minute, then the powders
are wetted with distilled water and milled by a hand oper-
ated pestle for one minute more. The cylindrical speci-
mens (1.27 cm D, 6 mm H) are enclosed in a steam
saturated atmosphere at one of the following tempera-
tures 37, 60, 80,100, and 120°C, and with a maximum
vapour tension of 1 atm. These conditions were used so as
not to increase the powder crystalline status. Thirty sam-
ples were prepared at each temperature and at each
composition.
Bovine bone samples, used as reference, were obtained
from the local slaughter-house. The bone was washed
with acetone (analytical grade), than manually crashed by
means of an iron hammer and homogenized in a stainless
steel blender running at full speed (21000 rpm).
Results
Characterization of calcium phosphate powders
The powders are characterized by X-ray powder diffraction
(Philips model 1730/10) and by scanning electron micro-
scopy (Jeol model JSM-T330) and morphometry. Powder
solubility in water at 25°C, (72 hours) has been evaluated
by calcium complexonometric quantitative analysis [26].
Two suspensions are prepared by mixing either 30 g of
HAp or 30 g of M in 1 l of distilled water. Six more
X-ray diffraction patterns of powders Figure 1
X-ray diffraction patterns of powders; X-ray powder diffrac-
tion patterns of: a) commercial hydroxyapatite powder, b) 
commercial monetite powder, c) compact bovine bone 
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mixtures are prepared suspending HAp and M at known
weight ratios, HAp/M (table 1). Water is added to each
mixture (1 l to 30 g), incubated at 25°C, and the calcium
concentrations are determined at 3, 6, 12, 24, 48 and 72
hours, by the complexonometric method [26].
The XRD traces for the hydroxyapatite and monetite pow-
ders are presented in figure (1a,1b). Each peak is com-
pared with those of pure hydroxyapatite and monetite by
ASTM standards [27]. Also shown, in figure 1c, is the X-ray
diffraction pattern of bovine bone, showing its low
cristallinity.
Morphometric and statistical analisys, of scanning elec-
tron microscopy studies (figure 2a) shows that the
hydroxyapatite powder is constituted of grains between 1
and 7 micron diameter. The grains (figure 3a) that are 1–
2 microns diameter, represent 65.8% of the total, those
that are 2–4 microns are 24.6% and those between 4 and
7 microns are 9.6%. Aggregates less than 2 microns are
composed of smaller grains that are about 100 nm in
diameter.
Observing monetite powder by scanning electron micros-
copy (figure 2b), we see that it is composed of three
groups of aggregates: the first consists of grains 1–2
microns diameter and constitute 52% of the total, the
second is grains 2–4 microns diameter (29%), and the
third, grains 4–6 microns diameter (19%) (figure 3b).
The hydroxyapatite and monetite solubilization time
courses of the several mixtures at 25°C for 72 h is reported
in figure 4a. The calcium concentration from HAp/M sus-
pensions is higher than in both pure HAp and M. The Ca2+
concentration at 72 hours in hydroxyapatite suspension is
0.23 mmoles/l and in monetite suspension is 0.78
mmoles/l. In mixture (c) (table 1) at 72 h, the Ca2+ con-
centration is 1.51 mmoles/l, and in mixture (g) is 1.61
mmoles/l. The curves in figure 4a show that the solubility
gradually increases over 72 hours reaching a plateau. The
pH values of the several suspensions over the 72 hours are
presented in figure 4b. The values of both the HAp and M
solutions are within the 6.7–7.0 pH range, and those of
their mixtures are within 6.0–6.6 pH range. Clearly, the
HAp and M powder mixtures with water excess induce
chemical reactions such as monetite hydrolysis. Most
probably this happens because monetite is the most solu-
ble and acidic compound.
Characterization of manufactured samples
All of the calcium phosphate samples that we produced
were characterized by X-ray powder diffraction (XRD),
Vickers hardness test (HV), scanning electron microscopy
(SEM), and porosity evaluation.
Electron scanning micrographs of pure powders Figure 2
Electron scanning micrographs of pure powders; Electron 
scanning micrographs of: a) commercial hydroxyapatite pow-
der, b) commercial monetite powder.
Table 1: Composition of Hap/M mixtures.
Mixtures 
names
Composititon (% in weight 
of hydroxyapatie and 
moneite)
Hydroxyapatite/
Monetite (moles 
ratios)
a Hap 100% /
b Hap 90%-M 10% 2.4:1
c Hap 80%-M20% 1:1
d Hap 70%-M30% 2:3
e Hap 60%-M40% 2:5
f Hap 50%-M50% 1:3
g Hap 30%-M70% 1:8
h M 100% /
Composition of the studied HAp/M mixtures and their molar ratios.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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Vickers hardness tests (HV) was carried out by Microhard-
ness tester (Type M) Shimadzu (Japan) and the porosity
was evaluated by a mercury porosimeter (Porosimeter
2000) Carlo Erba (Italy).
The X-ray diffraction patterns of powders from our sam-
ples (e.g. mixtures (a), (h), (f)) show patterns typical of
HAp and M powders (figure 1a and 1b, figure 5, respec-
tively). After thermal treatment at temperatures between
37°C and 120°C, neither any new crystal phase formed
nor was there an increase of the relative intensity of the
peaks (that is a cristallinity increase), for example see in
figure 6 the mixtures (h) and (f) at 120°C, but not the
mixture (a) alone.
Frequency distribution of particle dimension in powders Figure 3
Frequency distribution of particle dimension in powders; Fre-
quency distribution of particle dimensions of: a) commercial 
hydroxyapatite powder, b) commercial monetite powder.
Calcium concentration and pH values of the several mixtures Figure 4
Calcium concentration and pH values of the several mix-
tures; a) Final calcium concentration in water of HAp, M and 
HAp/M mixtures measured within 72 hours from mixing, b) 
pH values of HAp, M and HAp/M mixtures measured within 
72 hours from mixing.
X-ray diffraction pattern of specimen Figure 5
X-ray diffraction pattern of specimen; X-ray powder diffrac-
tion patterns of untreated manufactured sample f.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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Vickers hardness data are reported in table 2 and in figure
7 as the mean of 30 independent determinations for each
mixture and each treatment temperature in saturated
steam environment, and are expressed as GPa, according
to the designation E 92-82 from ASTM standards [28] and
SI units. An unpaired Student-t test was performed on the
data for the same mixture at different temperatures, and
also for the mixtures at each temperature, as shown in
table 3.
Table 2: HV data (GPa) and standard deviation (SD) of manufacts made by eight mixtures HAp/M treated in a steam satured 
environment at 37-60-80-100-120°C.
MISCEL
A
37° 60° 80° 100° 120°
HV SD HV SD HV SD HV SD HV SD
a 0.1420 0.0158 0.1210 0.0144 0.1020 0.0150 0.0930 0.0186 0.1130 0,0203
b 0.1210 0.0236 0.1450 0.0264 0.1440 0.0178 0.1420 0.0285 0.1570 0.0322
c 0.2150 0.0160 0.2020 0.0308 0.2460 0.0264 0.1970 0.0295 0.2220 0.0362
d 0.1280 0.0107 0.1430 0.0105 0.1550 0.0211 0.1400 0.0080 0.1440 0.0160
e 0.1420 0.0052 0.1190 0.0050 0.1360 0.0184 0.1290 0.0153 0.1760 0.0240
f 0.2230 0.0254 0.2180 0.0180 0.2080 0.0479 0.1750 0.0250 0.2360 0.0291
g 0.1610 0.0222 0.1530 0.0179 0.1650 0.0135 0.1630 0.0196 0.1780 0.0192
h 0.1290 0.0152 0.1050 0.0195 0.1050 0.0223 0.1400 0.0151 0.1210 0.0291
HV data (GPa) and standard deviations (SD) of manufactured samples made with the mixtures described in table 1.
X-ray powder diffraction patterns of specimens Figure 6
X-ray powder diffraction patterns of specimens; X-ray pow-
der diffraction patterns of samples treated at 120°C and pro-
duced with: a) hydroxyapatite (sample a), b) monetite 
(sample b), c) hydroxyapatite/monetite (sample f).
HV data of specimens Figure 7
HV data of specimens; HV data of manufactured samples 
made with the mixtures described in table 1 at the several 
treatment temperatures.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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There was no relationship found between HV and treat-
ment temperature of the mixtures. Much more significant
is the relationship of HV with mixture composition, and
only in two of the samples is HV higher than in the other
mixtures. That is the specimens with HAp/M mixtures (c)
and (f), that have HV values within the 0.20–0.25 GPa
range. HV values of specimens obtained with HAp have a
mean value of 0.11 GPa, those from M have a mean value
of 0.10 GPa.
The total porosity, as determined by mercury porosimeter,
in samples (c) and (f) decreases in the range of 50–60%,
Table 3: Results of unpaired t Student-t test performed on the HV data
M100% HAp30%+M70% HAp50%+M50% HAp60%+M40% HAp70%+M30% HAp80%+M20% HAp90%+M10%
HAp 100% p < 0.01 p < 0.005 p < 0.0005 n.s. p < 0.005 p < 0.0005 p < 0.005
HAp90%+M10% n.s. p < 0.0005 p < 0.0005 p < 0.005 n.s. p < 0.0005
HAp80%+M20% p < 0.0005 p < 0.0005 p < 0.1 p < 0.0005 p < 0.0005
HAp70%+M30% n.s. p < 0.0005 p < 0.0005 p < 0.0005
HAp60%+M40% p < 0.005 p < 0.0005 p < 0.0005
HAp50%+M50% p < 0.0005 p < 0.0005
HAp30%+M70% p < 0.0005
M100% HAp30%+M70% HAp50%+M50% HAp60%+M40% HAp70%+M30% HAp80%+M20% HAp90%+M10%
HAp 100% p < 0.005 p < 0.0005 p < 0.0005 n.s. p < 0.0005 p < 0.0005 p < 0.0005
HAp90%+M10% p < 0.0005 n.s. p < 0.0005 p < 0.0005 n.s. p < 0.0005
HAp80%+M20% p < 0.0005 p < 0.0005 p < 0.025 p < 0.0005 p < 0.0005
HAp70%+M30% p < 0.0005 p < 0.025 p < 0.0005 p < 0.0005
HAp60%+M40% p < 0.005 p < 0.0005 p < 0.0005
HAp50%+M50% p < 0.0005 p < 0.0005
HAp30%+M70% p < 0.0005
M100% HAp30%+M70% HAp50%+M50% HAp60%+M40% HAp70%+M30% HAp80%+M20% HAp90%+M10%
HAp 100% n.s. p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005
HAp90%+M10% p < 0.0005 p < 0.0005 p < 0.0005 p < 0.1 P < 0.05 p < 0.0005
HAp80%+M20% p < 0.0005 p < 0.0005 p < 0.005 p < 0.0005 p < 0.0005
HAp70%+M30% p < 0.0005 p < 0.005 p < 0.0005 p < 0.005
HAp60%+M40% p < 0.0005 p < 0.0005 p < 0.0005
HAp50%+M50% p < 0.0005 p < 0.0005
HAp30%+M70% p < 0.0005
M100% HAp30%+M70% HAp50%+M50% HAp60%+M40% HAp70%+M30% HAp80%+M20% HAp90%+M10%
HAp 100% p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005
HAp90%+M10% n.s. p < 0.1 p < 0.0005 p < 0.025 n.s. p < 0.0005
HAp80%+M20% p < 0.0005 p < 0.0005 p < 0.01 p < 0.0005 p < 0.0005
HAp70%+M30% n.s. p < 0.0005 p < 0.0005 p < 0.005
HAp60%+M40% p < 0.025 p < 0.0005 p < 0.0005
HAp50%+M50% p < 0.0005 p < 0.05
HAp30%+M70% p < 0.0005
M100% HAp30%+M70% HAp50%+M50% HAp60%+M40% HAp70%+M30% HAp80%+M20% HAp90%+M10%
HAp 100% n.s. p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005 p < 0.0005
HAp90%+M10% p < 0.0005 p < 0.01 p < 0.0005 p < 0.025 p < 0.1 p < 0.0005
HAp80%+M20% p < 0.0005 p < 0.0005 p < 0.1 p < 0.0005 p < 0.0005
HAp70%+M30% p < 0.0005 p < 0.005 p < 0.0005 p < 0.0005
HAp60%+M40% p < 0.0005 n.s. p < 0.0005
HAp50%+M50% p < 0.0005 p < 0.0005
HAp30%+M70% p < 0.0005
Results of unpaired t Student-t test performed on the HV data obtained from manufactured samples prepared with different mixtures and treated 
at each temperature.
Table 4: Porosity percentage of specimens
Samples untreated 37°C 60°C 120°C
a 67.45 71.78 59.36 50.14
c 59.35 50.63 49.02 52.55
f 61.44 41.36 37.21 48.67
Porosity percentage of a, c, f manufactured samples (see Table 1) at 
the described temperatures.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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Pore distribution analysis of the (c) and (f) samples after
thermal treatment shows three groups by pore sizes. They
are characterized by pores 0.004–0.07 microns in
diameter, 0.07–0.4 microns and 4–7 microns (about 1%).
Figure 8 shows the pore distribution analysis of sample (f)
thermally untreated (figure 8a), and treated at 60°C (fig-
ure 8b). By comparison, a sample of compact bovine bone
shows both 0.01–0.1 micron and 0.6–6 micron pores (fig-
ure 8c).
Scanning electron microscopy of the surfaces of speci-
mens (c) and (f) (figures 9a,9b) show a cohesion of the
powders grains. Here (c) is more compact in comparison
to (f), despite the presence of small pores. Observing the
fracture surfaces of samples (c) and (f) we see long crystals
of monetite with small grains of the hydroyapatite above
them (figures 10a,10b). In the (c) sample the monetite
crystals are spaced further apart, in the (f) sample the
monetite crystals overlap each other.
Discussion
As described in the section above, all tested HAp/M pow-
ders mixtures were more soluble in water than those of
pure compounds. According to these data, we assumed
that in samples made from HAp/M mixtures, a partial sol-
ubilization of the chemicals occurs. This process should
be useful to enhance the mixing of the reactants and the
production of fillers composed of newly formed HAp
crystals in the microspaces among the grains, and to
obtain an higher coherence in manufactured samples.
The results described demonstrate the complexity of the
systems, even those with heterogeneous compositions
and prepared with constant parameters such as tempera-
ture. To interpret the phenomena that occur in the proc-
esses that compact these specimens, it is useful to consider
that these processes occur within micropores [29]. In such
microspaces, many processes occur at grain and micro-
pore interfaces, which probably contain an oversaturated
environment.
The manufactured samples are treated at temperatures
between 37° and 120°C in a steam saturated environ-
ment to allow powders to solubilize without alteration of
their crystallinity. Calcium phosphates are then precipi-
tated into the grain interfaces without increasing HAp and
M crystallinity, as demonstrated by X-ray diffraction
studies of pure compounds. The thermal process always
determines an higher coherence in the products [30,31].
This hypothesis is supported by the porosity % results,
which decrease with thermal treatment, even if slightly, in
samples (c) and (f), (table 4).
In HAp/M samples, the solubilization and reprecipitation
processes are accelerated, Ca2+ and HPO4
2+ ion concentra-
tions increase and then the ions are precipitated as HAp.
Moreover, we should consider solubility of the initial
inorganic components, and the formation of hydrolysis
products (also at supersaturation, near the interfaces).
They could precipitate by nucleation on grain surfaces
(figures 10a,10b), producing intermediates with several
solubility products. It is also useful to consider mechani-
cal tests that show that temperature and vapour tension
gradients can occur throughout the specimen thickness
(table 2, figure 7). It is useful to note that standard
treatment procedures do not necessarily give the same
hardening with cement-like reaction within the several
shapes and volumes of the samples. Scanning electron
microscopy images of both external and fracture surfaces
(that is external and internal surfaces) (figures 9a,9b and
Distribution of pore volume in percentage Figure 8
Distribution of pore volume in percentage; Relative volume 
percentage distribution of pores in function of pore radiuses: 
a) sample f untreated, b) sample f treated at 60°C, c) sample 
of compact bovine bone.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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10a,10b) of the samples show different coherence of the
grains, some times with several crystals distributions
between the external surfaces and the interior regions of
the specimens. Hydroxyapatite is fragile, based on its low
reactivity in freshly distilled water, (i.e., pH = 7), so that
its grains do not sufficiently set to give mechanical consist-
ency to the specimen.
Samples of (c) and (f) mixtures show the highest HV val-
ues (0.20–0.25 GPa). These results demonstrate that the
HAp to M stoichiometric ratios (1:1 and 1: 3) optimize
the solubilization-reprecipitation process at grain
interfaces.
To compare with our results from the fillers and cements
tested, we used a specimen of bovine compact bone with
the same instrument and the same experimental condi-
tions, and determined the mean HV value of 0.42 GPa.
The morphology of sample (c) by scanning electron
microscopy of the fractured surface is shown in figures 9a
and 10a. Samples (c) and (f) show three groups by pore
size, whereas a specimen of compact bovine bone show
10–100 nm pore size and 0.6–5 micron macropores. On
the basis of the previous discussion of hydroxyapatite and
monetite specimens, we obtained samples with mechani-
cal properties useful to apply as either cements or fillers at
mild temperature and pressure conditions. Such products
can be further enhanced by the use of other inorganic
Electron scanning micrographs of external surface of  specimens Figure 9
Electron scanning micrographs of external surface of speci-
mens; a) External surface by scanning electron micrographs 
of type c (table 1) manufactured sample. b) External surface 
by scanning electron micrographs of type f (table 1) manufac-
tured sample.
Electron scanning micrographs of fracture surfaces of  specimens Figure 10
Electron scanning micrographs of fracture surfaces of speci-
mens; a) Fracture surface by scanning electron micrographs 
of type c (table 1) manufactured sample. b) Fracture surface 
by scanning electron micrographs of type f (table 1) manufac-
tured sample.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/8
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components the bone, and can easily be reabsorbed and
repopulated by the surrounding bone tissue.
Conclusions
In summary, based on our experimental data, we con-
clude that a solubilization-reprecipitation process occur,
which is more intensive in specimens of 80% hydroxyap-
atite (HAp) with 20% monetite (M) (c), and of 50% HAp
with 50% M (f), as demonstrated by Vickers hardness
data. The manufacturing process is carried out at low
temperature and in a steam saturated environment to
obtain more consistent materials, without altering pow-
ders crystallinity. These HAp/M samples show pore
dimension distribution, which is useful to cellular repop-
ulation if implanted in living tissues.
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